NextCure, Inc. (NXTC) Financials
NXTC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 139.9 million | 13.5 million |
2023-06-30 | 153.4 million | 15.0 million |
2023-03-31 | 167.8 million | 13.6 million |
2022-12-31 | 184.2 million | 16.6 million |
NXTC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -13.1 million | 2.0 million |
2023-06-30 | -15.0 million | 2.1 million |
2023-03-31 | -15.0 million | 2.1 million |
2022-12-31 | -9.8 million | 2.3 million |
NXTC Net Income
No data available :(
NXTC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 118.2 million | - | 6.1 million |
2023-06-30 | 130.6 million | - | 6.3 million |
2023-03-31 | 145.5 million | - | 6.5 million |
2022-12-31 | 159.9 million | - | 7.1 million |
NXTC Shares Outstanding
NXTC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 279000 | 11.0 million | 4.6 million | - |
2023-06-30 | 280000 | 13.4 million | 5.7 million | - |
2023-03-31 | 248000 | 11.6 million | 5.4 million | - |
2022-12-31 | 865000 | 12.8 million | 4.9 million | - |
NXTC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 946000 |
2023-06-30 | - | 1.1 million |
2023-03-31 | - | 1.1 million |
2022-12-31 | - | 1.4 million |
NXTC
Price: $1.30
52 week price:
Earnings Per Share: -2.25 USD
P/E Ratio: -0.56
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 224200
Market Capitalization: 60.8 million